Regeneron Pharmaceuticals, Inc. (REGN)
772.15
+17.24
(+2.28%)
USD |
NASDAQ |
Feb 11, 12:26
Regeneron Pharmaceuticals EPS Diluted (Quarterly) : 7.857 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.45 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| Merck & Co., Inc. | 1.191 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 844.60M |
| Revenue (Quarterly) | 3.884B |
| Total Expenses (Quarterly) | 3.040B |
| Enterprise Value | 74.17B |
| Gross Profit Margin (Quarterly) | 81.22% |
| Profit Margin (Quarterly) | 21.74% |
| Earnings Yield | 5.38% |
| Operating Earnings Yield | 4.41% |
| Normalized Earnings Yield | 5.272 |